{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-006512","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.443881+00:00","generated_at":"2026-05-22T15:43:30.189084+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bio-Techne authorizes $500M share repurchase program, replacing prior 2022 authorization","bullets":["Board authorized up to $500M in common stock repurchases on April 30, 2025.","Replaces the prior $500M program approved February 2, 2022; no expiration date set.","Repurchases may be made in open market, private transactions, or block trades.","Management retains discretion based on market conditions, stock price, and capital needs.","Program intends to offset dilution from stock option exercises among other purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-006512","json":"https://secwatch.observer/filing/0001558370-25-006512.json","markdown":"https://secwatch.observer/filing/0001558370-25-006512.md","text":"https://secwatch.observer/filing/0001558370-25-006512.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000155837025006512/0001558370-25-006512-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000155837025006512/tech-20250430x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T15:43:30.189084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}